JPS5756464A - Imidazole derivative ahd inhibitor for biosyntesis of thromboxane a2 - Google Patents

Imidazole derivative ahd inhibitor for biosyntesis of thromboxane a2

Info

Publication number
JPS5756464A
JPS5756464A JP55130643A JP13064380A JPS5756464A JP S5756464 A JPS5756464 A JP S5756464A JP 55130643 A JP55130643 A JP 55130643A JP 13064380 A JP13064380 A JP 13064380A JP S5756464 A JPS5756464 A JP S5756464A
Authority
JP
Japan
Prior art keywords
thromboxane
inhibitor
halogen
compound shown
biosyntesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP55130643A
Other languages
English (en)
Japanese (ja)
Other versions
JPS622586B2 (cs
Inventor
Tadao Tauchi
Masanori Kawamura
Tadanori Okada
Masaki Hayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kissei Pharmaceutical Co Ltd
Ono Pharmaceutical Co Ltd
Original Assignee
Kissei Pharmaceutical Co Ltd
Kissei Yakuhin Kogyo KK
Ono Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical Co Ltd, Kissei Yakuhin Kogyo KK, Ono Pharmaceutical Co Ltd filed Critical Kissei Pharmaceutical Co Ltd
Priority to JP55130643A priority Critical patent/JPS5756464A/ja
Priority to GB8128515A priority patent/GB2084150B/en
Priority to DE19813137674 priority patent/DE3137674A1/de
Priority to US06/304,531 priority patent/US4346099A/en
Publication of JPS5756464A publication Critical patent/JPS5756464A/ja
Publication of JPS622586B2 publication Critical patent/JPS622586B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/41Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by hydrogenolysis or reduction of carboxylic groups or functional derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP55130643A 1980-09-22 1980-09-22 Imidazole derivative ahd inhibitor for biosyntesis of thromboxane a2 Granted JPS5756464A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP55130643A JPS5756464A (en) 1980-09-22 1980-09-22 Imidazole derivative ahd inhibitor for biosyntesis of thromboxane a2
GB8128515A GB2084150B (en) 1980-09-22 1981-09-21 Imidazole derivatives
DE19813137674 DE3137674A1 (de) 1980-09-22 1981-09-22 Imidazolderivate und pharmazeutische mittel, welche diese derivate enthalten
US06/304,531 US4346099A (en) 1980-09-22 1981-09-22 Carboxy-imidazole derivatives, compositions and use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP55130643A JPS5756464A (en) 1980-09-22 1980-09-22 Imidazole derivative ahd inhibitor for biosyntesis of thromboxane a2

Publications (2)

Publication Number Publication Date
JPS5756464A true JPS5756464A (en) 1982-04-05
JPS622586B2 JPS622586B2 (cs) 1987-01-20

Family

ID=15039148

Family Applications (1)

Application Number Title Priority Date Filing Date
JP55130643A Granted JPS5756464A (en) 1980-09-22 1980-09-22 Imidazole derivative ahd inhibitor for biosyntesis of thromboxane a2

Country Status (3)

Country Link
JP (1) JPS5756464A (cs)
DE (1) DE3137674A1 (cs)
GB (1) GB2084150B (cs)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6034160A (ja) * 1983-08-05 1985-02-21 Nippon Saitetsuku Kk 保存食品の製法
WO1995015951A1 (fr) * 1993-12-10 1995-06-15 Kyorin Pharmaceutical Co. Ltd. Nouveau derive de l'imidazole et sa methode d'obtention

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54109974A (en) * 1978-02-18 1979-08-29 Kissei Pharmaceut Co Ltd Novel imidazolecarboxylic ester derivative
JPS54109973A (en) * 1978-02-17 1979-08-29 Kissei Pharmaceut Co Ltd Novel imidazole derivative
JPS54112863A (en) * 1978-02-20 1979-09-04 Kissei Pharmaceut Co Ltd N-(omega-carboxyalkyl)imidazole
JPS54163573A (en) * 1978-06-09 1979-12-26 Ono Pharmaceutical Co Imidazole derivative and method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2016452B (en) * 1978-02-18 1982-07-21 Kissei Pharmaceutical Imidazole compounds
IT1162310B (it) * 1978-05-02 1987-03-25 Ono Pharmaceutical Co Derivati di imidazolo e procedimento per produrli
JPS55313A (en) * 1978-06-13 1980-01-05 Kissei Pharmaceut Co Ltd Imidazole derivative

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54109973A (en) * 1978-02-17 1979-08-29 Kissei Pharmaceut Co Ltd Novel imidazole derivative
JPS54109974A (en) * 1978-02-18 1979-08-29 Kissei Pharmaceut Co Ltd Novel imidazolecarboxylic ester derivative
JPS54112863A (en) * 1978-02-20 1979-09-04 Kissei Pharmaceut Co Ltd N-(omega-carboxyalkyl)imidazole
JPS54163573A (en) * 1978-06-09 1979-12-26 Ono Pharmaceutical Co Imidazole derivative and method

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6034160A (ja) * 1983-08-05 1985-02-21 Nippon Saitetsuku Kk 保存食品の製法
WO1995015951A1 (fr) * 1993-12-10 1995-06-15 Kyorin Pharmaceutical Co. Ltd. Nouveau derive de l'imidazole et sa methode d'obtention
US6103747A (en) * 1993-12-10 2000-08-15 Kyorin Pharmaceutical Co., Ltd. Imidazole derivatives and process for preparing the same

Also Published As

Publication number Publication date
DE3137674A1 (de) 1982-05-19
GB2084150B (en) 1984-07-04
GB2084150A (en) 1982-04-07
DE3137674C2 (cs) 1989-12-28
JPS622586B2 (cs) 1987-01-20

Similar Documents

Publication Publication Date Title
JPS55313A (en) Imidazole derivative
HUT38309A (en) Process for preparing new prostaglandin derivatives and pharmaceutical compositions containing such active substance
GB1351430A (en) Substituted 1,2,4-triazole derivatives
ES8601146A1 (es) Procedimiento para preparar derivados azolicos
HU895226D0 (en) Process for the preparation of novel imidazoline derivatives and pharmaceutical compositions containing said compounds as active ingredients
ES8407487A1 (es) "un procedimiento para la preparacion de un triazol"
ES8506629A1 (es) Un procedimiento para preparar derivados de piridina
ES8402813A1 (es) Procedimiento para preparar amidas con propiedades herbicidas o fumigicidas.
ES8504653A1 (es) Un procedimiento para preparar nuevos derivados de eteno
ES8606362A1 (es) "un procedimiento para preparar un derivado de cefem".
ES8504682A1 (es) Un procedimiento para la preparacion de compuestos nitro alifaticos
JPS55129284A (en) 3-(1-imipazolyl)indolin-2-one
JPS5756464A (en) Imidazole derivative ahd inhibitor for biosyntesis of thromboxane a2
ES8306480A1 (es) Procedimiento para la obtencion de derivados de azolil-fenoxisustituidos.
ES8201156A1 (es) Procedimiento para la obtencion de derivados de triazolilfe-nacil-piridil-eter, de efecto fungicida
EP0123962A3 (en) Novel benzimidazole derivative, process for the preparation thereof and pharmaceutical composition
HUP9802348A2 (hu) 2-Fenil-3-aroil-benzotiofének alkalmazása plazminogén aktivátor inhibitor-1 gátló hatású gyógyszerkészítmények előállítására
ES8303393A1 (es) Un procedimiento para preparar derivados del acido ascorbico.
ES8305680A1 (es) Un procedimiento para la preparacion de derivados de etanolamina.
ES481314A1 (es) Procedimiento para la preparacion de halogenobenzoin-o-metil-eter-oximas.
JPS57183761A (en) Carbostyril derivative
ES8802512A1 (es) Proceso para producir derivados de 1,4-dihidro-piridina-3,5-dicarboxilato
HUP9801327A2 (hu) Benzotiofénszármazékok felhasználása a petefészekrák gátlására alkalmas gyógyszerkészítmények előállítására
JPS5770872A (en) Imidazole derivative and biosynthetic inhibitor against thromboxana a2 containg the same
ES8305377A1 (es) Un procedimiento para la preparacion de un derivado de nitrosourea.